First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 182.1 USD 0.97%
Updated: Mar 29, 2024

Abbvie Inc
Accrued Liabilities

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

Abbvie Inc
Accrued Liabilities Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$7.7B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
13%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$15.4B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.7B
CAGR 3-Years
24%
CAGR 5-Years
34%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
16%
CAGR 5-Years
25%
CAGR 10-Years
29%
Seagen Inc
NASDAQ:SGEN
Accrued Liabilities
$729.9m
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also